Date: 2020-10-01
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
Date: 2020-06-29
Repligen Announces Agreement to Acquire Engineered Molding Technology
Date: 2019-04-26
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies
Date: 2018-09-04
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
Date: 2018-06-28
Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand
Date: 2018-06-27
Repligen Announces Agreement with Navigo Proteins for the Exclusice Co-Development of Next Generation Affinity Ligands
Date: 2017-06-23
Repligen Corporation and Spectrum Inc. to Join Forces
Date: 2016-12-15
Repligen acquires TangenX Technology Corporation
Date: 2016-10-04
Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification
Date: 2016-04-04
Repligen acquires Atoll GmbH
